Disease | autosomal dominant polycystic kidney disease |
Comorbidity | C0022658|kidney disease |
Sentences | 8 |
PubMedID- 22425799 | Objectives: the aim of this study was to analyse the factors influencing chronic kidney disease (ckd) progression in patients with autosomal dominant polycystic kidney disease (adpkd). |
PubMedID- 25759590 | The results of this study show that higher rates of mru and costs (in all stages of kidney disease) were associated with adpkd patients, and transitions between ckd disease stages increased with each progressive disease stage. |
PubMedID- 22691223 | Case presentation: a 57-year-old asian man with end-stage kidney disease due to autosomal dominant polycystic kidney disease received a living kidney graft from his brother. |
PubMedID- 24707279 | A large clinical study evaluating the effects of lanreotide on kidney volume and gfr in adpkd patients with polycystic kidney disease is now ongoing in the netherlands. |
PubMedID- 19887788 | Methods: 101 adpkd patients with chronic kidney disease stages 1-5 were recruited and gfr was measured with the (51)cr-edta clearance method, and estimated with the modification of diet in renal disease study (mdrd) equation with 4 variables, the chronic kidney disease epidemiology collaboration (ckd-epi) equation, the cockcroft-gault equation adjusted for body surface area and the mdrd equation with cystatin c. |
PubMedID- 24007508 | adpkd is the cause of chronic kidney disease (ckd) in 5% of patients undergoing renal replacement therapy (rrt) in the usa [4], a rate that rises to 7.9% in our geographic area [5]. |
PubMedID- 25899445 | The calculation of the sample size is based on the results of the most comprehensive follow-up of adpkd patients with advanced kidney disease. |
PubMedID- 21525961 | Polycystic kidney disease: renal transplantation in patients with adpkd--the good, the bad and ugly. |
Page: 1